Alluvi tirzepatide appears to have emerged as a promising therapeutic candidate for the management of metabolic disorders. This preclinical evaluation assessed the efficacy and profile of tirzepatide 40mg in experimental models of type 2 diabetes. The studies demonstrated that tirzepatide 40mg significantly enhanced glycemic control and decreased i